(11th, 17th) 17-hydroxi-11 4-4 (methylene sulfur) phenyl - 17-17 (pentafluoro) esa-4.9-dien-3

摘要

The invention relates to (11ß, 17ß) -17-hydroxy-11– [4– (methylsulfonyl) phenyl] –17– (pentafluo¬roethyl) estra – 4,9-dien-3-one of formula and pharmaceutical compositions which they comprise, with antagonistic action at the progesterone receptor, useful in the treatment and / or prevention of diseases, especially uterine fibroids (fibroids, uterine leiomyomas),Endocrine disorders, severe menstrual bleeding, meningitis, hormonal breast cancer and menopausal disorders.